Evidence map›Paper›PMID 34180025›Full record

ArticleIntensive care medicine experimental2021

Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.

Lucas M Fleuren, Michele Tonutti, Daan P de Bruin, Robbert C A Lalisang, Tariq A Dam, Diederik Gommers, Olaf L Cremer, Rob J Bosman, Sebastiaan J J Vonk, Mattia Fornasa and 49 more

Abstract read
In one paragraph

Article in Intensive care medicine experimental, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors.

Lucas M Fleuren *Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands. l.fleuren@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-4056-1692
Michele Tonutti *Pacmed, Amsterdam, The Netherlands.
Daan P de BruinPacmed, Amsterdam, The Netherlands.
Robbert C A LalisangPacmed, Amsterdam, The Netherlands.
Tariq A DamDepartment of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Diederik GommersDepartment of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands.
Olaf L CremerIntensive Care, UMC Utrecht, Utrecht, The Netherlands.
Rob J BosmanICU, OLVG, Amsterdam, The Netherlands.
Sebastiaan J J VonkPacmed, Amsterdam, The Netherlands.
Mattia FornasaPacmed, Amsterdam, The Netherlands.
Tomas MachadoPacmed, Amsterdam, The Netherlands.
Nardo J M van der MeerIntensive Care, Amphia Ziekenhuis, Breda en Oosterhout, The Netherlands.
Sander RigterDepartment of Anesthesiology and Intensive Care, St. Antonius Hospital, Nieuwegein, The Netherlands.
Evert-Jan WilsDepartment of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Tim FrenzelDepartment of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Dave A DongelmansDepartment of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Remko de JongIntensive Care, Bovenij Ziekenhuis, Amsterdam, The Netherlands.
Marco PetersIntensive Care, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Marlijn J A KampsIntensive Care, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands.
Dharmanand RamnarainIntensive Care, ETZ Tilburg, Tilburg, The Netherlands.
Ralph NowitzkyIntensive Care, Haga Ziekenhuis, Den Haag, The Netherlands.
Fleur G C A NooteboomIntensive Care, Laurentius Ziekenhuis, Roermond, The Netherlands.
Wouter de RuijterIntensive Care, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands.
Louise C Urlings-StropIntensive Care, Reinier de Graaf Gasthuis, Delft, The Netherlands.
Ellen G M SmitIntensive Care, Spaarne Gasthuis, Haarlem en Hoofddorp, The Netherlands.
D Jannet Mehagnoul-SchipperIntensive Care, VieCuri Medisch Centrum, Venlo, The Netherlands.
Tom DormansIntensive Care, Zuyderland MC, Heerlen, The Netherlands.
Cornelis P C de JagerDepartment of Intensive Care, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands.
Stefaan H A HendriksIntensive Care, Albert Schweitzerziekenhuis, Dordrecht, The Netherlands.
Evelien OostdijkICU, Maasstad Ziekenhuis Rotterdam, Rotterdam, The Netherlands.
Auke C ReidingaICU, SEH, BWC, Martiniziekenhuis, Groningen, The Netherlands.
Barbara Festen-SpanjerIntensive Care, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.
Gert BrunnekreefDepartment of Intensive Care, Ziekenhuisgroep Twente, Almelo, The Netherlands.
Alexander D CornetDepartment of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands.
Walter van den TempelDepartment of Intensive Care, Ikazia Ziekenhuis Rotterdam, Rotterdam, The Netherlands.
Age D BoelensAnesthesiology, Antonius Ziekenhuis Sneek, Sneek, The Netherlands.
Peter KoetsierIntensive Care, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.
Judith LensICU, IJsselland Ziekenhuis, Capelle aan den IJssel, The Netherlands.
Sefanja AchterbergICU, Haaglanden Medisch Centrum, Den Haag, The Netherlands.
Harald J FaberICU, WZA, Assen, The Netherlands.
A KarakusDepartment of Intensive Care, Diakonessenhuis Hospital, Utrecht, The Netherlands.
Menno BeukemaDepartment of Intensive Care, Streekziekenhuis Koningin Beatrix, Winterswijk, The Netherlands.
Robert EntjesDepartment of Intensive Care, Admiraal De Ruyter Ziekenhuis, Goes, The Netherlands.
Paul de JongDepartment of Anesthesia and Intensive Care, Slingeland Ziekenhuis, Doetinchem, The Netherlands.
Taco HouwertPacmed, Amsterdam, The Netherlands.
Hidde HovenkampPacmed, Amsterdam, The Netherlands.
Roberto Noorduijn LondonoPacmed, Amsterdam, The Netherlands.
Davide QuintarelliPacmed, Amsterdam, The Netherlands.
Martijn G ScholtemeijerPacmed, Amsterdam, The Netherlands.
Aletta A de BeerPacmed, Amsterdam, The Netherlands.
Giovanni CinàPacmed, Amsterdam, The Netherlands.
Martijn BeudelDepartment of Neurology, Amsterdam UMC, Universiteit Van Amsterdam, Amsterdam, The Netherlands.
Nicolet F de KeizerDepartment of Clinical Informatics, Amsterdam UMC, Amsterdam, The Netherlands.
Mark HoogendoornQuantitative Data Analytics Group, Department of Computer Science, Faculty of Science, VU University, Amsterdam, The Netherlands.
Armand R J GirbesDepartment of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Willem E HerterPacmed, Amsterdam, The Netherlands.
Paul W G ElbersDepartment of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Patrick J ThoralDepartment of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Dutch ICU Data Sharing Against COVID-19 Collaborators

Funding

ZonMw 10430012010003
6 · The paper itself

Abstract

backgroundThe identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator-free days and ICU-free days during the course of invasive mechanical ventilation (IMV) in COVID-19 patients.

methodsThe DDW is a growing electronic health record database of critically ill COVID-19 patients in the Netherlands. All adult ICU patients on IMV were eligible for inclusion. Transfers, patients admitted for less than 24 h, and patients still admitted at time of data extraction were excluded. Predictors were selected based on the literature, and included medication dosage and fluid balance. Multiple algorithms were trained and validated on up to three sets of observations per patient on day 1, 7, and 14 using fivefold nested cross-validation, keeping observations from an individual patient in the same split.

resultsA total of 1152 patients were included in the model. XGBoost models performed best for all outcomes and were used to calculate predictor importance. Using Shapley additive explanations (SHAP), age was the most important demographic risk factor for the outcomes upon start of IMV and throughout its course. The relative probability of death across age values is visualized in Partial Dependence Plots (PDPs), with an increase starting at 54 years. Besides age, acidaemia, low P/F-ratios and high driving pressures demonstrated a higher probability of death. The PDP for driving pressure showed a relative probability increase starting at 12 cmH

conclusionAge is the most important demographic risk factor of ICU mortality, ICU-free days and ventilator-free days throughout the course of invasive mechanical ventilation in critically ill COVID-19 patients. pH, P/F ratio, and driving pressure should be monitored closely over the course of mechanical ventilation as risk factors predictive of these outcomes.

Indexed as

COVID-19Machine learningMortality predictionRisk factors

Identifiers

PMID34180025
PMCPMC8236316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.